Previous 10 | Next 10 |
Biolife Solutions, Inc. (BLFS) Q2 2020 Earnings Conference Call August 06, 2020, 16:30 ET Company Participants Roderick de Greef - CFO, COO & Secretary Michael Rice - President, CEO & Director Conference Call Participants Jacob Johnson - Stephens Inc. Marc Wiesenber...
Image source: The Motley Fool. Biolife Solutions Inc (NASDAQ: BLFS) Q2 2020 Earnings Call Aug 6, 2020 , 4:30 p.m. ET Operator Continue reading
The following slide deck was published by BioLife Solutions, Inc. in conjunction with their 2020 Q2 earnings Read more ...
BioLife Solutions (NASDAQ: BLFS ) : Q2 Non-GAAP EPS of -$0.01; GAAP EPS of -$0.70 misses by $0.67 . More news on: BioLife Solutions, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
BOTHELL, Wash. , Aug. 6, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced financial results for the t...
BOTHELL, Wash. , July 30, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced that the Company's second ...
BOTHELL, Wash. , July 15, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided an update on ...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 165 weeks of public selections as part of this ongoing live forward-testing resea...
BOTHELL, Wash. , July 7, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the closing of its public o...
BioLi f e Solutions (NASDAQ: BLFS) , which makes products that are used in the production of cell and gene therapies, is up 11.9% at 1:55 p.m. EDT after the company announced preliminary revenue for the second quarter and used the opportunity to raise $75 million. BioLife Solutions estimat...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...